High levels of Mcl-1 and Bcl-2 have been identified in B-cell chronic lymphocytic leukemia (CLL) [242], a type of cancer that is extremely resistant to many types of treatment. This evidence concerns the gene BCL2 and B-cell chronic lymphocytic leukemia.